RenovoRx, Inc.

Renovorx, Inc.

Biotechnology • Healthcare • Mountain View, CA, United States • RNXT (NCM)

RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Mountain View, California.

650 284 4433 2570 West El Camino Real, Mountain View, CA 94040, United States

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

RenovoRx (NASDAQ: RNXT) reports $900K YTD revenue; 14 centers approved for RenovoCath - Stock Titan
Stock Titan • Nov 13
What analysts say about RNXT stock - Risk-Reward Ratio Analysis & Free Dynamic Profit Opportunities - earlytimes.in
earlytimes.in • Dec 30
Shaun Bagai buys RenovoRx (RNXT) shares worth $4506 By Investing.com - Investing.com Nigeria
Investing.com Nigeria • Dec 22
New Analyst Forecast: $RNXT Given $12.5 Price Target | RNXT Stock News - Quiver Quantitative
Quiver Quantitative • Nov 24
Crane NXT (CXT): Assessing Valuation After a Recent 15% Share Price Slide - Yahoo Finance
Yahoo Finance • Dec 16

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has RenovoRx, Inc. had layoffs?
No layoff events have been recorded for RenovoRx, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does RenovoRx, Inc. have?
RenovoRx, Inc. has approximately 10 employees.
What industry is RenovoRx, Inc. in?
RenovoRx, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is RenovoRx, Inc. a publicly traded company?
Yes, RenovoRx, Inc. is publicly traded under the ticker symbol RNXT on the NCM. The company has a market capitalization of approximately $0.03 billion.
Where is RenovoRx, Inc. headquartered?
RenovoRx, Inc. is headquartered in Mountain View, CA, United States at 2570 West El Camino Real, Mountain View, CA 94040, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.